Claudia Kedor

1.6k total citations · 2 hit papers
33 papers, 791 citations indexed

About

Claudia Kedor is a scholar working on Psychiatry and Mental health, Neurology and Rheumatology. According to data from OpenAlex, Claudia Kedor has authored 33 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 9 papers in Neurology and 8 papers in Rheumatology. Recurrent topics in Claudia Kedor's work include Fibromyalgia and Chronic Fatigue Syndrome Research (15 papers), Long-Term Effects of COVID-19 (9 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Claudia Kedor is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (15 papers), Long-Term Effects of COVID-19 (9 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Claudia Kedor collaborates with scholars based in Germany, Switzerland and Chile. Claudia Kedor's co-authors include Carmen Scheibenbogen, Helma Freitag, Kirsten Wittke, Judith Bellmann–Strobl, Frank Konietschke, Friedemann Paul, Leif G. Hanitsch, Franziska Sotzny, Gordon Rudolf and Sandra Bauer and has published in prestigious journals such as Nature Communications, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Claudia Kedor

32 papers receiving 773 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity

2022 169 citations Claudia Kedor, Helma Freitag et al. Nature Communications profile →
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)

2022 168 citations Helma Freitag, Gordon Rudolf et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudia Kedor Germany	13	398	297	128	119	118	33	791
Kirsten Wittke Germany	13	453 1.1×	415 1.4×	122 1.0×	135 1.1×	87 0.7×	24	894
Thomas Harbo Denmark	19	1.2k 3.0×	91 0.3×	44 0.3×	104 0.9×	69 0.6×	32	1.6k
Larissa Hauer Austria	18	337 0.8×	54 0.2×	41 0.3×	81 0.7×	76 0.6×	29	850
Helma Freitag Germany	15	474 1.2×	405 1.4×	123 1.0×	38 0.3×	110 0.9×	29	997
Svetlana Blitshteyn United States	14	396 1.0×	153 0.5×	49 0.4×	26 0.2×	44 0.4×	43	833
Kamalesh Chakravarty India	15	196 0.5×	50 0.2×	46 0.4×	31 0.3×	53 0.4×	50	563
Jose Torres United States	16	699 1.8×	36 0.1×	50 0.4×	25 0.2×	54 0.5×	63	1.2k
Mihaela Simu Romania	18	402 1.0×	89 0.3×	46 0.4×	43 0.4×	73 0.6×	82	899
David Houghton United States	17	782 2.0×	54 0.2×	25 0.2×	19 0.2×	168 1.4×	41	1.2k
Joel C. Morgenlander United States	20	423 1.1×	153 0.5×	19 0.1×	9 0.1×	125 1.1×	61	994

Countries citing papers authored by Claudia Kedor

Since Specialization

Citations

This map shows the geographic impact of Claudia Kedor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Kedor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Kedor more than expected).

Fields of papers citing papers by Claudia Kedor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Kedor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Kedor. The network helps show where Claudia Kedor may publish in the future.

Co-authorship network of co-authors of Claudia Kedor

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Kedor. A scholar is included among the top collaborators of Claudia Kedor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Kedor. Claudia Kedor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meyer‐Arndt, Lil, Claudia Kedor, Kirsten Wittke, et al.. (2025). Functional olfactory impairment and fatigue in post-COVID-19 syndrome including ME/CFS – a longitudinal prospective observational study. Brain Behavior & Immunity - Health. 50. 101124–101124.

Sotzny, Franziska, Claudia Kedor, Helma Freitag, et al.. (2025). Serum Spike Protein Persistence Post COVID Is Not Associated with ME/CFS. Journal of Clinical Medicine. 14(4). 1086–1086. 2 indexed citations

Kedor, Claudia, et al.. (2025). Pyridostigmine improves hand grip strength in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Frontiers in Neuroscience. 19. 1637838–1637838. 1 indexed citations

Steinbeis, Fridolin, Claudia Kedor, Charlotte Thibeault, et al.. (2024). A new phenotype of patients with post-COVID-19 condition is characterised by a pattern of complex ventilatory dysfunction, neuromuscular disturbance and fatigue symptoms. ERJ Open Research. 10(5). 1027–2023. 1 indexed citations

Wittke, Kirsten, Claudia Kedor, Rebekka Rust, et al.. (2024). Efficacy of repeated immunoadsorption in patients with post-COVID myalgic encephalomyelitis/chronic fatigue syndrome and elevated β2-adrenergic receptor autoantibodies: a prospective cohort study. The Lancet Regional Health - Europe. 49. 101161–101161. 8 indexed citations

Kedor, Claudia, Rebekka Rust, Helma Freitag, et al.. (2024). Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Journal of Clinical Medicine. 13(7). 2153–2153. 4 indexed citations

Meyer‐Arndt, Lil, Claudia Kedor, Helma Freitag, et al.. (2023). Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort. EClinicalMedicine. 63. 102146–102146. 52 indexed citations

Wittke, Kirsten, Claudia Kedor, Helma Freitag, et al.. (2023). Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies—An Interim Report. Journal of Clinical Medicine. 12(19). 6428–6428. 9 indexed citations

Kedor, Claudia, et al.. (2023). Characterizing Sjögren-Associated Fatigue: A Distinct Phenotype from ME/CFS. Journal of Clinical Medicine. 12(15). 4994–4994. 3 indexed citations

10.

Hanitsch, Leif G., Sophie Steiner, Michael Schümann, et al.. (2023). Portal hypertension in common variable immunodeficiency disorders – a single center analysis on clinical and immunological parameter in 196 patients. Frontiers in Immunology. 14. 1268207–1268207. 5 indexed citations

11.

Kedor, Claudia, et al.. (2023). Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis. Frontiers in Immunology. 13. 1045523–1045523. 15 indexed citations

12.

Henes, Jörg, Sebastian Saur, David M. Kofler, et al.. (2022). Tocilizumab for the Treatment of Familial Mediterranean Fever—A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Journal of Clinical Medicine. 11(18). 5360–5360. 12 indexed citations

13.

Kedor, Claudia, Helma Freitag, Lil Meyer‐Arndt, et al.. (2022). A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nature Communications. 13(1). 5104–5104. 169 indexed citations breakdown →

14.

Kedor, Claudia, J. Detert, Rolf Rau, et al.. (2021). Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study—a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. RMD Open. 7(2). e001660–e001660. 24 indexed citations

15.

Kedor, Claudia, et al.. (2021). Update on the therapy of adult-onset Still’s disease with a focus on IL-1-inhibition: a systematic review. Therapeutic Advances in Musculoskeletal Disease. 13. 1759720X211059598–1759720X211059598. 11 indexed citations

16.

Freitag, Helma, S. Lorenz, Franziska Sotzny, et al.. (2021). Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Frontiers in Immunology. 12. 644548–644548. 14 indexed citations

17.

Kedor, Claudia, Joachim Listing, Jan Zernicke, et al.. (2020). Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Annals of the Rheumatic Diseases. 79(8). 1090–1097. 64 indexed citations

18.

Zernicke, Jan, Claudia Kedor, Angela Müller, et al.. (2016). A prospective pilot study to evaluate an animated home-based physical exercise program as a treatment option for patients with rheumatoid arthritis. BMC Musculoskeletal Disorders. 17(1). 351–351. 13 indexed citations

19.

Kedor, Claudia, Jan Zernicke, Lorena Martinez‐Gamboa, et al.. (2016). A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren’s syndrome. Clinical Rheumatology. 35(9). 2203–2210. 13 indexed citations

20.

Kedor, Claudia, et al.. (2015). THU0399 Effectiveness and Safety of Low-Dose Cyclosporine a in Patients with Primary Sjögren's Syndrome (PSS) with Articular Involvement – Results of a Pilot Study. Annals of the Rheumatic Diseases. 74. 341–341. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact